Covering the Cover Gastroenterology

Slides:



Advertisements
Similar presentations
Volume 150, Issue 2, Pages e6 (February 2016)
Advertisements

Covering the Cover Gastroenterology
Volume 147, Issue 3, Pages (September 2014)
Not All Effects of a Gluten-Free Diet Are Due to Removal of Gluten
Submucosal Tunneling Endoscopic Resection for En Bloc Removal of Large Esophageal Gastrointestinal Stromal Tumors  Nikhil A. Kumta, Monica Saumoy, Amy.
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Outcomes Among Living Liver Donors
Covering the Cover Gastroenterology
How to Critically Read the GI Epidemiology Literature
The Functional Gastrointestinal Disorders and the Rome III Process
Gastroenterology 2011–2016: Looking Back and Forward
Tissue-Engineered Cell Sheets for Stricture Prevention: A New Connection Between Endoscopy and Regenerative Medicine  Joshua D. Penfield, Emmanuel C.
Volume 154, Issue 5, Pages (April 2018)
Covering the Cover Gastroenterology
Clinical Challenges and Images in GI
Volume 147, Issue 3, Pages (September 2014)
Volume 133, Issue 3, Pages e1 (September 2007)
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Volume 147, Issue 3, Pages e1 (September 2014)
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 135, Issue 4, Pages (October 2008)
Management of Patients With Functional Heartburn
Volume 150, Issue 4, Pages (April 2016)
Yutaka Tomizawa, Lei Zhao, Leslie W. Yang  Gastroenterology 
Functional Dyspepsia Is Associated With Sleep Disorders
Volume 145, Issue 1, Pages (July 2013)
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Laura Rotundo, Sushil Ahlawat  Gastroenterology 
Covering the Cover Gastroenterology
The 75th Diamond Anniversary of Gastroenterology: 1943–2018
Volume 153, Issue 4, Pages (October 2017)
Covering the Cover Gastroenterology
Eva S. Schernhammer, Shuji Ogino, Charles S. Fuchs  Gastroenterology 
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Constance E. Ruhl, James E. Everhart  Gastroenterology 
Volume 133, Issue 2, Pages (August 2007)
Targeted Therapies for Hepatocellular Carcinoma
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Volume 156, Issue 4, Pages (March 2019)
Volume 149, Issue 6, Pages (November 2015)
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
New Epidemiologic Evidence on Functional Dyspepsia Subgroups and Their Relationship to Psychosocial Dysfunction  Lukas Van Oudenhove, Jan Tack  Gastroenterology 
Richard J. Saad, William D. Chey  Gastroenterology 
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Changing of the Guards: 2011–2016 Gastroenterology Team
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Esophageal Tumor After Radical Surgery for Gastric Cancer
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
An Unusual Cause of Life-Threatening Upper Gastrointestinal Bleeding
A Rare Tumor of the Liver With a Sudden Presentation
Presentation transcript:

Covering the Cover Gastroenterology Anson W. Lowe, Richard H. Moseley  Gastroenterology  Volume 147, Issue 3, Pages 547-549 (September 2014) DOI: 10.1053/j.gastro.2014.07.024 Copyright © 2014 AGA Institute Terms and Conditions

Figure 1 (A) Esophageal tissue homogenate IgG4 content, as milligrams per gram of total protein, is increased 45-fold (95% confidence interval, 7.5–109; P < 3 × 10-5). Esophageal tissue homogenate IgG4 content is a mean of 17% ± 8% of total IgG in the eosinophilic esophagitis subjects and 0.92% ± 0.43% in normal controls (P < 3 × 10-5). (B) Immunofluorescent staining for IgG4 in an eosinophilic esophagitis subject shows patchy granular intercellular IgG4, in red, with a blue DAPI nuclear counterstain. (C) The control has no IgG4 staining. (B and C) Co-staining for complement 9 (green) is negative. Granular IgG4 is found in 21 of 24 eosinophilic esophagitis cases and in 0 of 9 controls (P = 6 × 10-6). Gastroenterology 2014 147, 547-549DOI: (10.1053/j.gastro.2014.07.024) Copyright © 2014 AGA Institute Terms and Conditions

Figure 2 Absolute differences between the study groups in changes in the (A) GSRS, (B) PGWB, and (C) SF-36 scores. The differences in changes between the intervention group (GFD) and the normal diet group (gluten) are shown after 1 year of study enrollment and are expressed as means and 95% confidence intervals. On the GSRS, higher scores denote more severe gastrointestinal symptoms, on the PGWB higher scores denote better self-perceived quality of life, and on the SF-36 higher scores denote better health status and quality of life. Values in each subdimension scores are calculated as a mean of the relevant items. EP, emotional problems; PP, physical problems. Gastroenterology 2014 147, 547-549DOI: (10.1053/j.gastro.2014.07.024) Copyright © 2014 AGA Institute Terms and Conditions

Figure 3 Overall survival is improved among CpG island methylator phenotype (CIMP)-positive tumors (solid lines) for whom irinotecan is added to fluorouracil and leucovorin (IFL). Gastroenterology 2014 147, 547-549DOI: (10.1053/j.gastro.2014.07.024) Copyright © 2014 AGA Institute Terms and Conditions